Executive Summary

Investment Thesis: Sempra reported Q3 2026 EPS of $1.40, beating consensus by roughly $0.18, supported by stronger Oncor equity earnings and infrastructure performance. Analysts maintain a Strong Buy consensus and a mean price target near $95, implying roughly 21.6% upside from the November 6 close. The company offers a 3.35% dividend yield and trades at a mid-teens P/E, but elevated debt, ongoing large-scale capital spending and recent share underperformance temper near-term upside.

Current Price: $78.17 as of Friday, November 6 | Key Metric: P/E 16.67 | Stance: NEUTRAL

Company Overview

Sempra ($SRE) is a North American energy infrastructure company operating regulated utilities, energy infrastructure assets and growth projects. The business mixes steady regulated cash flows with growth investments that include transmission, distribution and large energy projects.

Key Products & Competitive Position

Core Business: Regulated electric and gas utilities, and utility-scale energy infrastructure investments.
Key Products: Electricity and gas distribution through utility subsidiaries, equity investments in transmission and distribution, and contracted infrastructure projects.
Competitive Moat: Large regulated footprints, scale in infrastructure development, long-term contracted cash flows and regulatory relationships that support predictable returns.

Recent Developments

Q3 2026 results, released on November 5 and reported broadly on November 6, showed an earnings beat and guidance commentary that pushed management toward the high end of adjusted EPS guidance for 2026. Oncor, where Sempra has a material equity exposure, posted meaningful net income for the quarter and updated its base capital plan, which supports Sempra's infrastructure earnings outlook. Management highlighted progress on 2026 value creation initiatives and signaled confidence in adjusted EPS for the year.

Financial Snapshot

Market Cap$51.12B

P/E Ratio16.67

52-Week Range$76.21 - $101.04

Dividend Yield3.35%

EPS (TTM)$4.68

ROE9.43%

Revenue & Earnings Trends

Sempra's trailing revenue sits in the low tens of billions annually, and reported Q3 showed year over year revenue improvement in segments tied to Oncor and infrastructure performance. Q3 EPS of $1.40 rose sharply from $1.11 a year earlier, representing a notable sequential improvement and a beat of the consensus estimate of about $1.22. While underlying regulated earnings are relatively stable, revenue growth can be lumpy when project timing and equity earnings swings occur.

Balance Sheet Highlights

The company carries sizable debt as typical for large utility and infrastructure owners. Total debt is in the high tens of billions, producing a debt to equity ratio near 85% per recent public data. The current ratio of 1.61 indicates near-term liquidity is adequate, while free cash flow has been pressured by heavy capex linked to growth and capital plans. Operating cash flow remains positive and material, which supports funding for capital needs when combined with access to capital markets.

Valuation Analysis

Current Valuation Metrics

Forward P/E14.11vs Industry: mid-teens

PEG RatioN/AGrowth-adjusted

EV/EBITDA~15.0vs Historical: slightly below recent peak

P/S Ratio~3.8vs Peers: higher due to infrastructure earnings

Historical Comparison

On a trailing P/E of about 16.7 Sempra sits in the mid-teens range that is broadly consistent with its historical trading band for the last several years. The EV/EBITDA near 15 reflects the combined effect of leverage and relatively stable EBITDA. Relative to the 52-week high, the current price reflects a meaningful de-rating from earlier multiples that factored in project progress and a more optimistic macro backdrop.

Fair Value Estimate

Analyst mean targets cluster near $95, with a median close to $97. That consensus implies a market-implied fair value in the mid-90s on current fundamentals and expected execution. A conservative DCF outlook that incorporates higher capex and normalized regulated returns produces a fair value range roughly between $85 and $105, with a midpoint near the analyst mean. These figures are estimates and sensitive to discount rates, long term growth assumptions and regulatory outcomes.

Competitive Landscape

Market Position

Market Share: Significant regional utility footprint in key states | Ranking: Top-tier U.S. utility and energy infrastructure owner

Key Competitors

NextEra Energy (NEE)NextEra Energy, large regulated utility and renewables developer

Dominion Energy (D)Dominion Energy, diversified utility with regulated and infrastructure assets

Duke Energy (DUK)Duke Energy, large regulated electric and gas operations

Competitive Advantages

Moat 1: Regulated utility cash flows that provide steady earnings and credit support.
Moat 2: Scale in infrastructure execution and access to project returns from transmission and distribution investments.
Moat 3: Long-standing regulatory relationships that help secure rate base growth and approved capital recovery.

Earnings Track Record

Last 4 Quarters: 3 beats / 1 misses

Recent Earnings History

Q3 2026$1.40 vs $1.22 estBEAT

Q2 2026Company reported better than prior-year comparablesBEAT

Q1 2026Mixed results, below some estimatesMISS

Q4 2025Solid execution on regulated returnsBEAT

Guidance Trend

Following the Q3 release, management updated 2026 GAAP EPS guidance and said it was guiding to the high end of the adjusted EPS range. That upward tilt reflects stronger Oncor equity earnings and progress on value creation initiatives. Analysts will watch whether management maintains this posture as capex and project timing evolve into 2027.

Analyst Sentiment

Consensus Rating: Strong Buy

Strong Buy: 4 Buy: 13 Hold: 5 Sell: 0

Price Targets

Low: $83
Mean: $95.06 (+21.6% upside)
High: $108

Recent Analyst Actions

Post-Q3 coverage has held an upbeat tone as analysts incorporate Oncor's strong quarterly net income and the company's message about guiding to the high end of adjusted EPS. A small group of analysts have nudged targets modestly higher while the overall distribution remained concentrated in the mid-to-high 90s on mean and median readings.

Recent News & Catalysts

Key Developments

Q3 Earnings Release (11/5/2026): Sempra reported EPS of $1.40, beating estimates. Management pointed to stronger Oncor equity earnings and infrastructure contributions.
Oncor Q3 Results (11/5/2026): Oncor reported net income that materially contributed to Sempra's equity earnings for the quarter and announced an expected 20% increase to its base capital plan.
Guidance Update (11/5/2026): The company advanced 2026 value creation initiatives and updated GAAP EPS guidance, indicating it expects to be at the high end of adjusted EPS guidance for 2026.

Upcoming Catalysts

Next Earnings: Next quarterly report expected in early 2027 | Key Events: Oncor capital plan developments, regulatory filings in jurisdictions where Sempra operates, project permitting and financing updates for infrastructure investments

Technical Outlook

Current Price: $78.17 vs 52-Week High: $101.04 (-22.6% from high)

Trend Analysis

Price action over the last six to twelve months shows weakness, with Sempra underperforming earlier highs. The stock has pulled back closer to its 52-week low, reflecting investor caution around leverage and capex. Short-term momentum indicators softened into the Q3 print, even though the quarter produced a headline beat. This leaves the technical picture mixed, with the potential for mean reversion if macro sentiment improves and execution stays on track.

Key Levels

Resistance: $85, $95
Support: $76.21, $70

Bull vs Bear Case

Bull Case

Catalyst 1: Continued strength in Oncor equity earnings lifts consolidated results and supports the high end of adjusted EPS guidance.
Catalyst 2: Successful execution of capital plan and project approvals drive rate base growth and raise long-term regulated returns.
Catalyst 3: Analyst models converge toward mid-90s targets as uncertainty around capital timing clears, making current valuation attractive relative to long-term cash flow potential.

Bull Target: $108 (+38% from $78.17)

Bear Case

Risk 1: Elevated debt and heavy capex create refinancing and cash flow pressure if interest rates or project costs rise.
Risk 2: Delays or regulatory setbacks in large infrastructure projects compress returns and reduce near-term earnings visibility.
Risk 3: Continued share weakness and broader market stress push multiples lower, amplifying downside if execution disappoints.

Bear Target: $65 (-17% from $78.17)

Risks to Consider

Valuation Risk: Although P/E is mid-teens, leverage and the large capital program mean valuation is sensitive to rate changes and execution outcomes.
Competitive Risk: Competitive dynamics in energy infrastructure and utility regulation can pressure allowed returns and delay rate base additions.
Macro Risk: Higher interest rates, inflation in construction costs, or adverse macro shocks could increase financing costs and compress project economics.
Execution Risk: Large infrastructure builds are subject to permitting, timeline and cost risk, which can affect free cash flow and credit metrics.

Bottom Line

Investment Verdict: NEUTRAL

Sempra presents a mixed risk-reward profile. The company delivered a notable Q3 beat and management signaled confidence in adjusted 2026 results, while analysts retain constructive price targets. At the same time, leverage, significant ongoing capex and recent share underperformance introduce material execution and market risks that temper the upside implied by analyst targets.

Action Items for Investors

Long-term investors: You may want to monitor progress on Oncor earnings, regulatory approvals and updates to the capital plan before reassessing allocation size.
Short-term traders: Watch technical support near $76 and resistance in the mid-80s for near-term patterns and volatility around macro headlines.
Risk management: Track leverage metrics, free cash flow trends and any guidance revisions closely, and consider position sizing to reflect execution risk.

What to Watch This Week

Follow analyst updates and any post-earnings revisions to models following the Q3 print.
Monitor headlines related to Oncor capital plan approvals and regulatory filings that could change growth visibility.
Watch macro moves in rates and energy project cost inflation that influence financing costs and project IRRs.

SRE: Q3 Beat, Mixed Risk/Reward